4th Jul 2008 07:00
TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):
Sinclair Pharma Plc
2. Reason for the notification (please place an X inside the appropriate bracket/s):
An acquisition or disposal of voting rights: ( X )
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( )
An event changing the breakdown of voting rights: ( )
Other (please specify) : ( )
Revised due to DTR rules - see Section 13
3. Full name of person(s) subject to the notification obligation (iii):
AXA S.A. , 25 Avenue Matignon, 75008 Paris, and its group of companies
4. Full name of shareholder(s) (if different from 3.) (iv):
5. Date of the transaction (and date on which the threshold is crossed or reached if different) (v):
2 July 2008
6. Date on which issuer notified:
3 July 2008
7. Threshold(s) that is/are crossed or reached:
9%
8. Notified details:
A: Voting rights attached to shares
Class/type of shares if Situation previous to the Triggering transaction possible using the ISIN (vi) CODE Number of shares Number of voting Rights (viii) 3385674 10,438,230 10,438,230
Resulting situation after the triggering transaction (vii)
Class/type of Number of shares Number of voting rights % of voting rightsshares if possible (ix) using the ISIN CODE Direct Direct Indirect (xi) Direct Indirect (x) 3385674 - - 7,823,230 0.00 8.36% B: Financial Instruments
Resulting situation after the triggering transaction (xii)
Type of Expiration Date Exercise/ Number of voting % of voting financial (xiii) Conversion Period/ rights that may be rights instrument Date (xiv) acquired if the instrument is exercised/ converted. Total (A+B)Number of voting % of voting rights rights 7,823,230 8.36%
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv):
Shares held Name of Company/Fund
745,000 AXA Framlington Xerox Final Salary Pension Scheme 521,500 AXA Framlington Islington Group Pension Scheme 250,000 AXA Framlington SEI UK Equity 1,250,000 AXA Framlington Framlington Innovative Growth 3,200,000 AXA Framlington Health 1,000,000 AXA Framlington UK Smaller Companies 600,230 AXA Framlington BAE Systems Pension Fund CIF Trustees 256,500 AXA Framlington BAE Systems 2000 Pensions Fund 7,823,230 TOTAL Proxy Voting:10. Name of the proxy holder:
11. Number of voting rights proxy holder will acquire to hold:
12. Date on which proxy holder will acquire to hold voting rights:
13. Additional information:
14. Contact name:
Alan Olby (Company Secretary) [email protected]
15. Contact telephone number: 01483 410600
vendorRelated Shares:
Sinclair Pharma